185 related articles for article (PubMed ID: 14675710)
21. Progression of gene hypermethylation in gallstone disease leading to gallbladder cancer.
House MG; Wistuba II; Argani P; Guo M; Schulick RD; Hruban RH; Herman JG; Maitra A
Ann Surg Oncol; 2003 Oct; 10(8):882-9. PubMed ID: 14527906
[TBL] [Abstract][Full Text] [Related]
22. Promoter hypermethylation profile of kidney cancer.
Dulaimi E; Ibanez de Caceres I; Uzzo RG; Al-Saleem T; Greenberg RE; Polascik TJ; Babb JS; Grizzle WE; Cairns P
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3972-9. PubMed ID: 15217927
[TBL] [Abstract][Full Text] [Related]
23. Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer.
Leung WK; To KF; Chu ES; Chan MW; Bai AH; Ng EK; Chan FK; Sung JJ
Br J Cancer; 2005 Jun; 92(12):2190-4. PubMed ID: 15942635
[TBL] [Abstract][Full Text] [Related]
24. Promoter hypermethylation of DAP-kinase is associated with poor survival in primary biliary tract carcinoma patients.
Tozawa T; Tamura G; Honda T; Nawata S; Kimura W; Makino N; Kawata S; Sugai T; Suto T; Motoyama T
Cancer Sci; 2004 Sep; 95(9):736-40. PubMed ID: 15471559
[TBL] [Abstract][Full Text] [Related]
25. Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas.
House MG; Guo M; Iacobuzio-Donahue C; Herman JG
Carcinogenesis; 2003 Feb; 24(2):193-8. PubMed ID: 12584167
[TBL] [Abstract][Full Text] [Related]
26. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
[TBL] [Abstract][Full Text] [Related]
27. [Hierarchical clustering analysis to detect associations between clinical and pathological features of gastric tumors and hypermethylation of suppressor genes].
Zavala G L; Luengo J V; Ossandón C F; Riquelme S E; Backhouse E C; Palma V M; Argandoña C J; Cumsille MA; Corvalán R A
Rev Med Chil; 2007 Jan; 135(1):17-25. PubMed ID: 17369979
[TBL] [Abstract][Full Text] [Related]
28. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs.
Graziano F; Arduini F; Ruzzo A; Mandolesi A; Bearzi I; Silva R; Muretto P; Testa E; Mari D; Magnani M; Scartozzi M; Cascinu S
Ann Oncol; 2004 Mar; 15(3):489-92. PubMed ID: 14998854
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer.
Misawa K; Mochizuki D; Imai A; Endo S; Mima M; Misawa Y; Kanazawa T; Carey TE; Mineta H
Oncotarget; 2016 May; 7(18):26087-98. PubMed ID: 27027429
[TBL] [Abstract][Full Text] [Related]
30. Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation.
Kang GH; Lee HJ; Hwang KS; Lee S; Kim JH; Kim JS
Am J Pathol; 2003 Oct; 163(4):1551-6. PubMed ID: 14507661
[TBL] [Abstract][Full Text] [Related]
31. Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract.
Phé V; Cussenot O; Rouprêt M
BJU Int; 2009 Oct; 104(7):896-901. PubMed ID: 19522860
[TBL] [Abstract][Full Text] [Related]
32. Specific patterns of gene methylation in natural killer cell lymphomas : p73 is consistently involved.
Siu LL; Chan JK; Wong KF; Kwong YL
Am J Pathol; 2002 Jan; 160(1):59-66. PubMed ID: 11786399
[TBL] [Abstract][Full Text] [Related]
33. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
Hoque MO; Topaloglu O; Begum S; Henrique R; Rosenbaum E; Van Criekinge W; Westra WH; Sidransky D
J Clin Oncol; 2005 Sep; 23(27):6569-75. PubMed ID: 16170165
[TBL] [Abstract][Full Text] [Related]
34. [Detection of free tumor-related DNA in the serum of breast cancer patients].
Zhang JJ; Ouyang T; Wan WH; Deng GR
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):609-13. PubMed ID: 18210882
[TBL] [Abstract][Full Text] [Related]
35. Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers.
Yanagawa N; Tamura G; Oizumi H; Takahashi N; Shimazaki Y; Motoyama T
Cancer Sci; 2003 Jul; 94(7):589-92. PubMed ID: 12841866
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic Regulation of CD133 in Gastrointestinal Stromal Tumors.
Geddert H; Braun A; Kayser C; Dimmler A; Faller G; Agaimy A; Haller F; Moskalev EA
Am J Clin Pathol; 2017 May; 147(5):515-524. PubMed ID: 28398518
[TBL] [Abstract][Full Text] [Related]
37. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
Hoque MO; Begum S; Topaloglu O; Jeronimo C; Mambo E; Westra WH; Califano JA; Sidransky D
Cancer Res; 2004 Aug; 64(15):5511-7. PubMed ID: 15289362
[TBL] [Abstract][Full Text] [Related]
38. Frequent intra-tumoural heterogeneity of promoter hypermethylation in malignant melanoma.
Rastetter M; Schagdarsurengin U; Lahtz C; Fiedler E; Marsch WCh; Dammann R; Helmbold P
Histol Histopathol; 2007 Sep; 22(9):1005-15. PubMed ID: 17523078
[TBL] [Abstract][Full Text] [Related]
39. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma.
Yu J; Zhang H; Gu J; Lin S; Li J; Lu W; Wang Y; Zhu J
BMC Cancer; 2004 Sep; 4():65. PubMed ID: 15367334
[TBL] [Abstract][Full Text] [Related]
40. Methylation status of nine tumor suppressor genes in multiple myeloma.
Braggio E; Maiolino A; Gouveia ME; Magalhães R; Souto Filho JT; Garnica M; Nucci M; Renault IZ
Int J Hematol; 2010 Jan; 91(1):87-96. PubMed ID: 20037750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]